Articles tagged "Liver"

2021 American Transplant Congress
A Novel Liver Assist Device as a Bridge to Liver Transplantation in Acute on Chronic Liver Failure Patients with Multi-Organ Failure
S. Ahmad¹, I. W. Liou¹, J. Reyes², R. Bakthavatsalam³, N. C. Smith⁴, R. L. Carithers¹, C. Martin¹, D. Gao⁵
¹Medicine, University of Washington, Seattle, WA, ²Surgery, University of Washington, SEATTLE, WA, ³Surgery, University of Washington, Seattle, WA, ⁴Nursing, University of Washington, Seattle, WA, ⁵Engineering, University of Washington, Seattle, WA
*Purpose: Acute on chronic liver failure (AOCLF) occurs in nearly 25% of patients with acutely decompensated cirrhosis, with many developing multi-organ failure requiring ventilatory, vasopressor…
2021 American Transplant Congress
Should We Curtail the Importance of Non-modifiable Risk Factors in Dcd Liver Risk Stratification?
R. Meier¹, Y. Kelly², S. Yamaguchi², H. Braun², T. Lunow-Luke², D. Adelmann², C. Niemann², D. Maluf¹, Z. Dietch², P. Stock², S. Kang², S. Feng², A. Posselt², J. Gardner², C. Freise², R. Hirose², C. Freise², N. Ascher², J. Roberts², G. Roll²
¹University of Maryland, Baltimore, Baltimore, MD, ²UCSF, San Francisco, CA
*Purpose: Scoring systems have been proposed to select donation after circulatory death (DCD) donors and recipients for liver transplantation (LT). We hypothesized that the generalizability…
2021 American Transplant Congress
Impact of Sars-cov-2 Infection in Waiting List for Liver Transplantation: A Cohort Study on Clinical Outcomes
A. Sessa, A. Mazzola, B. Granger, D. Wakselman, M. Atif, V. Martinez, M. Mallet Maxime, D. Thabut, O. Scatton, F. Conti
Hopital Pitie Salpetriere, Paris, France
*Purpose: Infections in cirrhotic patients are associated with an increased risk of liver-related complications (LRC) and mortality. Limited data regarding the prevalence of Coronavirus disease…
2021 American Transplant Congress
Geographic Divergence in Waitlist Registration and Trends in Waitlist Removal for Liver Transplantation in Patients with Nonalcoholic Steatohepatitis (NASH)
C. Hanlon¹, B. Saberi², L. Yuan¹
¹Internal Medicine - Transplant Hepatology, University of Southern California, Los Angeles, CA, ²Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Boston, MA
*Purpose: This study aims to evaluate regional trends of waitlist (WL) registrations and removal for liver transplantation (LT) among United States (US) adults listed for…
2021 American Transplant Congress
Impact of Graft Quality on Patient Survival in Sick Patients
G. Handing¹, S. Keeling¹, C. Christmann¹, N. Galvan², C. O’Mahony², J. Goss², R. Cotton², A. Rana²
¹School of Medicine, Baylor College of Medicine, Houston, TX, ²Michael E DeBakey Department of Surgery, Division of Abdominal Transplant, Houston, TX
*Purpose: It is widely accepted in the literature that patients who have a Model for End Stage Liver Disease (MELD) Score greater than 30 incur…
2021 American Transplant Congress
The Effect of Acuity Circles on Deceased Donor Transplant and Offer Rates Across Meld and Exception Statuses
A. Wey¹, S. Noreen², S. Gentry³, N. Salkowski¹, M. Cafarella², R. Hirose⁴, J. Trotter⁵, D. Segev⁶, A. Israni¹, J. Snyder¹, B. Kasiske¹
¹SRTR, Minneapolis, MN, ²UNOS, Richmond, VA, ³USNA, Annapolis, MD, ⁴Univ of San Francisco, San Francisco, CA, ⁵BSW Health, Dallas, TX, ⁶Johns Hopkins, Baltimore, MD
*Purpose: Acuity circles (AC) allocation was implemented on February 4, 2020. AC significantly changed the relative priority of candidates with allocation PELD/MELD scores of 29…
2021 American Transplant Congress
Validation of PROMIS Anxiety Computer Adaptive Test in Solid Organ Transplant Recipients
M. Saqib, M. Yang, F. Jamal, S. Aghamohammadi, G. Ahmadzadeh, M. Hamid, V. Shah, N. Jayakumar, M. Novak, I. Mucsi
University Health Network, Toronto, ON, Canada
*Purpose: To assess the validity and reliability of the PROMIS Anxiety item bank administered using Computer Adaptive Test (PROMIS-A CAT) in patients who received solid…
2021 American Transplant Congress
The Survival Benefits of Using Marginal Allografts in Liver Transplantation
T. H. Malik¹, E. L. Godfrey¹, A. Rana²
¹Baylor College of Medicine, Houston, TX, ²Department of Abdominal Transplantation, Baylor College of Medicine, Houston, TX
*Purpose: Our study assessed whether using marginal allografts at initial time of listing provided similar or greater survival benefit versus waiting on the transplant waitlist…
2021 American Transplant Congress
Liver Dysfunction Following Lung Transplantation
E. J. Hyzny¹, E. G. Chan¹, J. P. Ryan¹, T. Harano¹, M. R. Morrell², P. G. Sanchez¹
¹Cardiothoracic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, ²Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA
*Purpose: To describe the incidence and risk factors for postoperative hepatic dysfunction (POHD) following lung transplantation (LT) and long-term outcomes for these patients.*Methods: We performed…
2021 American Transplant Congress
Epigenetic & Functional Changes Associated with Alloreactive Memory CD8 T Cell Subsets in Liver Transplant Patients
H. Abdelsamed¹, S. Liu¹, M. Juya¹, D. Metes², F. Lakkis¹, A. Thomson¹
¹University of Pittsburgh Medical Center, Pittsburgh, PA, ²UPMC, Pittsburgh, PA
*Purpose: Donor-specific allo-reactive memory CD8 T cells play a pivotal role in allo-immunity and represent a major hurdle against tolerance induction in solid organ transplantation.…